Dergiler / Şişli Etfal Hastanesi Tıp Bülteni / 2018 / Cilt: 52 - Sayı: 4

Aldosterone Resistance Due to Tacrolimus: A Case Report

Sayfa
310–312
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

No response was detected after tacrolimus conversion to everolimus and consideringtubular dysfunction due to aldosterone resistance, we initiated fludrocortisone therapy and electrolyte disorders rapidly improved.Fludrocortisone therapy should be considered when hyponatremia and/or hyperkalemia due to tacrolimus are detectedin renal transplant patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Although more common with tacrolimus, it is known that calcineurin inhibitors may induce the development of electrolytedisorders such as hyponatremia and hyperkalemia by causing a hyporeninemic hypoaldosteronism-like syndrome.
📊
Temel Bulgular & Veri:We presenta 32-year-old female renal transplant patient who admitted to clinic with hyponatremia and hyperkalemia.
💡
Sonuç & Katkı:No response was detected after tacrolimus conversion to everolimus and consideringtubular dysfunction due to aldosterone resistance, we initiated fludrocortisone therapy and electrolyte disorders rapidly improved.Fludrocortisone therapy should be considered when hyponatremia and/or hyperkalemia due to tacrolimus are detectedin renal transplant patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Although more common with tacrolimus, it is known that calcineurin inhibitors may induce the development of electrolytedisorders such as hyponatremia and hyperkalemia by causing a hyporeninemic hypoaldosteronism-like syndrome. We presenta 32-year-old female renal transplant patient who admitted to clinic with hyponatremia and hyperkalemia. Normal anion gapmetabolic acidosis and renal tubular dysfunction were detected and after other reasons were excluded, it was considered aselectrolyte disorder due to tacrolimus. No response was detected after tacrolimus conversion to everolimus and consideringtubular dysfunction due to aldosterone resistance, we initiated fludrocortisone therapy and electrolyte disorders rapidly improved.Fludrocortisone therapy should be considered when hyponatremia and/or hyperkalemia due to tacrolimus are detectedin renal transplant patients.

🔖

Bu Makaleye Atıf Yap

ÇAĞLAYAN, F. B., KOÇ, Y., BAŞTÜRK, T., HASBAL, N. B., SAKACI, T., AHBAP, E., İSLAM, M., NAZİF, P., ÜNSAL, A. (2018). Aldosterone Resistance Due to Tacrolimus: A Case Report. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 52 - Sayı: 4, 310–312. https://ajindex.com/articles/364025

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Higgins R, Ramaiyan K, Dasgupta T, Kanji H, Fletcher S, Lam F, et al. Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities. Nephrol Dial Transplant. 2004;19:444–50
  2. Heering PJ, Kurschat C, Vo DT, Klein-Vehne N, Fehsel K, Ivens K. Aldosterone resistance in kidney transplantation is in partinduced by a down-regulation of mineralocorticoid receptorexpression. Clin Transplant 2004;18:186–92
  3. Bagchi S, Husain Zaidi S, Prasad Mathur R. Severe symptomatic hyponatremia--an uncommon presentationof tacrolimus nephrotoxicity. Nephrol Dial Transplant. 2011;26:2042–4
  4. Tumlin JA, Sands JM. Nephron segment-specific inhibition of Na+/ K(+)-ATPase activity by cyclosporin A. Kidney Int 1993;43:246–51
  5. Ferrer-Martínez A, Felipe A, Barceló P, Casado FJ, Ballarín J, Pastor- Anglada M. Effects of cyclosporine A on Na,K-ATPase expression in the renal epithelial cell line NBL-1. Kidney Int 1996;50:1483–9
  6. Deppe CE, Heering PJ, Viengchareun S, Grabensee B, Farman N, Lombès M. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology 2002;143:1932–41
  7. Heering PJ, Klein-Vehne N, Fehsel K. Decreased mineralocorticoid receptor expression in blood cellsof kidney transplant recipients undergoing immunosuppressivetreatment: cost efficient determination by quantitative PCR. J Clin Pathol 2004;57:33–6
  8. Sayin B. Tacrolimus-Induced Salt Losing Nephropathy Resolved AfterConversion to Everolimus. Transplant Direct 2015;1:e37
  9. Rabb HA, Niles JL, Cosimi AB, Tolkoff-Rubin NE. Severe hyponatremia associated with combined pancreatic and renal transplantation. Transplantation 1989;48:157–9.